✅ Prescription Required
Rx Mirataz® Transdermal Ointment – 5 gm
Mirataz® (mirtazapine transdermal ointment) is a veterinary prescription appetite stimulant for cats. FDA-approved, it is indicated for the management of weight loss in cats, especially those experiencing poor appetite due to chronic medical conditions. Applied topically to the inner ear, Mirataz® provides a convenient alternative to oral dosing.
Key Details:
-
Strength & Count: 5 gm tube.
-
Class: Appetite stimulant (tetracyclic antidepressant derivative).
-
Indication (Cats): Management of weight loss in cats, including those with poor appetite due to chronic illness.
-
Canine/Other Species Safety: Not approved for use in dogs or other species.
-
Use Only Under Vet Supervision: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for human use. In case of accidental exposure, wash skin immediately and seek medical attention. Wear gloves when applying the ointment to avoid accidental absorption.
-
Contraindications/Cautions: Do not use in cats with known hypersensitivity to mirtazapine. Use with caution in cats with hepatic or renal disease. Safety not established in breeding, pregnant, or lactating cats.
-
Storage: Store below 77°F (25°C). Do not freeze. Keep tightly closed when not in use.
Regulatory: Prescription required; federal law restricts this drug to use by or on the order of a licensed veterinarian.
Keep away from children and other household pets.
This item is not returnable or refundable.
Sold in Qty. of 1 (5 gm tube).
| Product type: |
Animal Health & Wellness > Medicine |
| Brand: |
Pet's Choice Pharmacy |
| Size: |
5gm |
| Status: |
Available |
| Animal type: |
Cat |
| Ingredients: |
See Product for details |
| Cautions & Warnings: |
Mirataz (mirtazapine transdermal ointment) is for topical use in cats only under veterinary supervision. Do not use in cats with a known hypersensitivity to mirtazapine or any of the excipients. Do not use in cats treated with monoamine oxidase inhibitors (MAOIs). Not for human use. Keep out of reach of children. Wear gloves when handling/applying, wash hands after and avoid contact between the treated cat and people or other animals for 2 hours following application. Use with caution in cats with hepatic and kidney disease. Cats food intake should be monitored upon discontinuation. Safety has not been evaluated in cats less than 2 kg, less than six months of age or in breeding, pregnant or lactating cats. The most common adverse reactions observed during clinical trials were application site reactions, behavioral abnormalities (vocalization and hyperactivity) and vomiting. |
| Dosage instructions: |
Administer topically by applying a 1.5-inch ribbon of ointment (approximately 2 mg/cat) on the inner pinna of the cats ear once daily for 14 days (see Diagrams on product). Wear disposable gloves when applying Mirataz. Dispose of used gloves after each application. Alternate the daily application of Mirataz between the left and right inner pinna of the ears. Do not administer into the external ear canal. If desired, the inner pinna of the cats ear may be cleaned by wiping with a dry tissue or cloth immediately prior to the next scheduled dose. If a dose is missed, apply Mirataz the following day and resume daily dosing. To demonstrate the method of administering the dose, the veterinarian or trained personnel at the clinic should apply the first dose in the presence of the owner. After application, care should be taken that people or other animals in the household do not come in contact with the treated cat for 2 hours because mirtazapine can be absorbed transdermally and orally. |
| Weight: |
0.05 |
| Prescription required: |
YES |
| GTIN: |
317033060056 |
